Delivery Order SPE2DR25D2211-SPE2DR26FM7A2
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Mounjaro 15 mg/0.5 mL pen injections, with a contract ceiling value of $1,666.62 and an ultimate completion date of December 11, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Mounjaro 15 mg/0.5 ml pen injections with a ceiling value of $1,580.52. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by November 18, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance and leverages its extensive federal pharmaceutical distribution...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 ml pen injections, with a contract ceiling value of $2,237.15. The award, issued on December 3, 2025, with an ultimate completion date of December 4, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is serving as the prime contractor for this pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Mounjaro 10 mg/0.5 ml pen injections valued at $7,989.68. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 12, 2025, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract carries no set-aside designation, reflecting the contractor's demonstrated capability to compete in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Mounjaro 15 mg/0.5 ml pen injectors valued at $24,712.54, with completion scheduled for December 2, 2025. This is a firm fixed-price delivery order issued under a non-competitive, non-set-aside procurement with performance to take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Mounjaro 15 mg/0.5 mL pens with a ceiling value of $1,048.38. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 16, 2025, with performance occurring at the contractor's location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Mounjaro 15 mg/0.5 ml pen injections, with a contract ceiling value of $1,053.68 and an ultimate completion date of December 10, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $4,214.72 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Mounjaro 15 mg/0.5 ml pen injections. The contract, which represents a non-set-aside competitive award, is scheduled for completion by November 18, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Mounjaro 10 mg/0.5 mL pen injectors with a ceiling value of $4,779.47 and completion date of December 16, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procurement procedures. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a $3,951.30 delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Mounjaro 5 mg/0.5 mL pen injections. This is a firm fixed-price delivery order with an ultimate completion date of December 12, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- SPE2DR25D2211Indefinite Delivery Contract
- SPE2DR25D2211-SPE2DR26FM7A2Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Mounjaro 15 mg/0.5 ml pen injections with a ceiling value of $10,536.80 and an ultimate completion date of December 17, 2025. This is a firm fixed-price delivery order issued under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award carries no set-aside designation and was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. This delivery order represents a routine pharmaceutical supply transaction within AmerisourceBergen's comprehensive federal contract portfolio with the Defense Logistics Agency. The company supplies an extensive range of medications and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. The Mounjaro product—a diabetes management medication—is consistent with AmerisourceBergen's track record of fulfilling federal medical supply requirements through delivery orders ranging from minimal to substantial values, demonstrating the vendor's capability to meet diverse military healthcare procurement needs across global operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.5k | 12/15/25 |